应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CLYM CLIMB BIO INC
交易中 12-23 11:28:56 EST
4.66
-0.24
-5.00%
最高
5.05
最低
4.47
成交量
65.61万
今开
5.00
昨收
4.90
日振幅
11.90%
总市值
3.17亿
流通市值
1.43亿
总股本
6,818万
成交额
306.05万
换手率
2.13%
流通股本
3,075万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Climb Bio, Inc.盘中异动 股价大涨5.61%
市场透视 · 12-22 22:31
Climb Bio, Inc.盘中异动 股价大涨5.61%
新闻稿:Climb Bio 根据纳斯达克上市规则 5635(c)(4) 报告激励股票奖励
投资观察 · 11-25
新闻稿:Climb Bio 根据纳斯达克上市规则 5635(c)(4) 报告激励股票奖励
CLIMB BIO INC 任命 Adam Villa 为技术运营高级副总裁,Ashley Jones 为人力资源与战略高级副总裁
美股速递 · 10-21
CLIMB BIO INC 任命 Adam Villa 为技术运营高级副总裁,Ashley Jones 为人力资源与战略高级副总裁
Climb Bio, Inc.2024财年第三财季实现净利润-8.90百万美元,同比减少124.18%
市场透视 · 2024-11-19
Climb Bio, Inc.2024财年第三财季实现净利润-8.90百万美元,同比减少124.18%
加载更多
公司概况
公司名称:
CLIMB BIO INC
所属市场:
NASDAQ
上市日期:
--
主营业务:
Climb Bio, Inc.于2018年10月18日作为特拉华州公司注册成立。该公司是一家生物技术公司,专注于开发神经元兴奋性障碍的新疗法,以解决精神病学、癫痫、慢性疼痛以及外周和中枢神经系统疾病方面未满足的需求。
发行价格:
--
{"stockData":{"symbol":"CLYM","market":"US","secType":"STK","nameCN":"CLIMB BIO INC","latestPrice":4.655,"timestamp":1766507319128,"preClose":4.9,"halted":0,"volume":656084,"delay":0,"floatShares":30748027,"shares":68184435,"eps":-0.75067,"marketStatus":"交易中","change":-0.245,"latestTime":"12-23 11:28:56 EST","open":5,"high":5.048,"low":4.465,"amount":3060453.405152,"amplitude":0.11898,"askPrice":4.66,"askSize":200,"bidPrice":4.65,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.75067,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1766523600000},"marketStatusCode":2,"adr":0,"listingDate":1628222400000,"exchange":"NASDAQ","adjPreClose":4.9,"preHourTrading":{"tag":"盘前","latestPrice":5.01,"preClose":4.9,"latestTime":"09:29 EST","volume":34882,"amount":179470.401504,"timestamp":1766500170054},"postHourTrading":{"tag":"盘后","latestPrice":5.39,"preClose":4.9,"latestTime":"19:59 EST","volume":28202,"amount":143213.1167,"timestamp":1766451584305},"volumeRatio":0.79786},"requestUrl":"/m/hq/s/CLYM","defaultTab":"news","newsList":[{"id":"2593435400","title":"Climb Bio, Inc.盘中异动 股价大涨5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593435400","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593435400?lang=zh_cn&edition=full","pubTime":"2025-12-22 22:31","pubTimestamp":1766413863,"startTime":"0","endTime":"0","summary":"北京时间2025年12月22日22时31分,Climb Bio, Inc.股票出现波动,股价快速拉升5.61%。Climb Bio, Inc.股票所在的生物技术行业中,整体涨幅为0.03%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Equillium, Inc.、Quantum Biopharma Ltd.涨幅较大,Pmgc Holdings Inc.、Psyence Biomedical Ltd.、Gt Biopharma, Inc.较为活跃,换手率分别为112.17%、15.05%、7.48%,振幅较大的相关个股有Novabay Pharmaceuticals, Inc.、Quantum Biopharma Ltd.、Gain Therapeutics, Inc.,振幅分别为9.31%、6.97%、6.53%。Climb Bio, Inc.公司简介:Climb Bio Inc是一家临床阶段的生物技术公司,为免疫介导性疾病患者开发治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222223103a46ae0ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222223103a46ae0ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLYM","BK4139","BK4539"],"gpt_icon":0},{"id":"1191476710","title":"新闻稿:Climb Bio 根据纳斯达克上市规则 5635(c)(4) 报告激励股票奖励","url":"https://stock-news.laohu8.com/highlight/detail?id=1191476710","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191476710?lang=zh_cn&edition=full","pubTime":"2025-11-25 20:07","pubTimestamp":1764072421,"startTime":"0","endTime":"0","summary":"美国马萨诸塞州韦尔斯利山,2025年11月25日-- Climb Bio, Inc.,一家开发针对免疫介导疾病的治疗药物的临床阶段生物技术公司,今天宣布,Climb Bio 根据其2025年修订的激励计划,向一名新员工授予了激励股票奖励,以激励该名员工与 Climb Bio 签署雇佣合同,符合纳斯达克上市规则 5635。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NVIW.SI","PSQ","BK4539","QID","QQQ","TQQQ","QLD","TSYW.SI","USAW.SI","USJW.SI","SQQQ","MNQmain",".IXIC","NQmain","CLYM"],"gpt_icon":1},{"id":"1185490852","title":"CLIMB BIO INC 任命 Adam Villa 为技术运营高级副总裁,Ashley Jones 为人力资源与战略高级副总裁","url":"https://stock-news.laohu8.com/highlight/detail?id=1185490852","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185490852?lang=zh_cn&edition=full","pubTime":"2025-10-21 19:02","pubTimestamp":1761044546,"startTime":"0","endTime":"0","summary":"CLIMB BIO INC 任命 Adam Villa 为技术运营高级副总裁,Ashley Jones 为人力资源与战略高级副总裁。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLYM","BK4539","BK4139"],"gpt_icon":0},{"id":"2484991306","title":"Climb Bio, Inc.2024财年第三财季实现净利润-8.90百万美元,同比减少124.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484991306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484991306?lang=zh_cn&edition=full","pubTime":"2024-11-19 18:00","pubTimestamp":1732010429,"startTime":"0","endTime":"0","summary":"11月19日,Climb Bio, Inc.公布财报,公告显示公司2024财年第三财季净利润为-8.90百万美元,同比减少124.18%;其中营业收入为0.00美元,每股基本收益为-0.13美元。从资产负债表来看,Climb Bio, Inc.总负债3.42百万美元,其中短期债务58000.00美元,资产负债比为0.65,流动比率为0.58。机构评级:截至2024年11月19日,当前有2家机构对Climb Bio, Inc.目标价做出预测,其中目标均价为4.50美元,其中最低目标价为4.00美元,最高目标价为5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180146a24562b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119180146a24562b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CLYM"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.eliemtx.com","stockEarnings":[{"period":"1week","weight":0.2861},{"period":"1month","weight":1.8824},{"period":"3month","weight":1.1778},{"period":"6month","weight":2.7692},{"period":"1year","weight":1.5128},{"period":"ytd","weight":1.7222}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":0.0391},{"period":"3month","weight":0.0326},{"period":"6month","weight":0.128},{"period":"1year","weight":0.1585},{"period":"ytd","weight":0.1685}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Climb Bio, Inc.于2018年10月18日作为特拉华州公司注册成立。该公司是一家生物技术公司,专注于开发神经元兴奋性障碍的新疗法,以解决精神病学、癫痫、慢性疼痛以及外周和中枢神经系统疾病方面未满足的需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.044593},{"month":2,"riseRate":0.5,"avgChangeRate":-0.039153},{"month":3,"riseRate":0.25,"avgChangeRate":-0.102291},{"month":4,"riseRate":0.75,"avgChangeRate":0.286337},{"month":5,"riseRate":0.5,"avgChangeRate":0.027501},{"month":6,"riseRate":0.25,"avgChangeRate":-0.069889},{"month":7,"riseRate":0.75,"avgChangeRate":0.07628},{"month":8,"riseRate":0.25,"avgChangeRate":0.096778},{"month":9,"riseRate":0.2,"avgChangeRate":-0.124516},{"month":10,"riseRate":0.4,"avgChangeRate":-0.049478},{"month":11,"riseRate":0,"avgChangeRate":-0.130257},{"month":12,"riseRate":0.6,"avgChangeRate":0.273009}],"exchange":"NASDAQ","name":"CLIMB BIO INC","nameEN":"CLIMB BIO INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CLIMB BIO INC(CLYM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CLIMB BIO INC(CLYM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CLIMB BIO INC,CLYM,CLIMB BIO INC股票,CLIMB BIO INC股票老虎,CLIMB BIO INC股票老虎国际,CLIMB BIO INC行情,CLIMB BIO INC股票行情,CLIMB BIO INC股价,CLIMB BIO INC股市,CLIMB BIO INC股票价格,CLIMB BIO INC股票交易,CLIMB BIO INC股票购买,CLIMB BIO INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CLIMB BIO INC(CLYM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CLIMB BIO INC(CLYM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}